Mark Henderson

BC life science powerhouses partner to commercialize targeted cancer therapies

Mark Henderson
May 29, 2019

A first-ever collaboration between CDRD and Triumf could put Canada on the fast track for tackling late stage cancer.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
Organizations: Advanced Accelerator Applications, BC Cancer Agency, CDRD, Fusion Pharmaceuticals, Institute for Advanced Medical Isotopes, McMaster University, Novartis, TRIUMF, TRIUMF Innovations, and University of British Columbia
People: Francois Bénard, Kathryn Hayashi, and Lana Janes
Topics: medical isotopes, nuclear medicine, and targeted alpha therapies

Other News

CIHR and partners invest $24.5M to study cannabis

Dark days ahead for R&D in Ontario?

Are we in danger of building another patriarchal system with the emergence of precision medicine?

The Short Report - May 22, 2019: Discovery Grants, IP Expert Panel, Cannabis and UFC






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.